---
title: "Clopidogrel pharmacogenomics: next steps. | Sutter Health"
description: "We outline the pathway for clopidogrel pharmacogenomics that needs to be taken for clinical translation to occur."
url: "https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research publications](https://www.sutterhealth.org/research/publications) /
4.  Clopidogrel pharmacogenomics: next steps.

# Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.

Gladding P1, Panattoni L, Webster M, Cho L, & Ellis S.

_JACC Cardiovasc Interv. 3(10):995-1000. doi: 10.1016/j.jcin.2010.08.012._

2010-10-01

## Abstract

Clopidogrel pharmacogenomics has received significant attention since a black box warning was announced by the Food and Drug Administration in March 2010.

This has left clinicians in a difficult situation where many questions remain unanswered.

In this brief viewpoint article, we ask some pointed questions of our own and outline the pathway that needs to be taken for clinical translation to occur.

[PubMed abstract](http://www.ncbi.nlm.nih.gov/pubmed/20965455)

## Research topics

-   [Cardiovascular Diseases](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Cardiovascular+Diseases%5C%22%22)
-   [Disease Management](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Disease+Management%5C%22%22)
-   [Genetics](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Genetics%5C%22%22)
-   [Health Policy](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Health+Policy%5C%22%22)
-   [Pharmacoepidemiology](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Pharmacoepidemiology%5C%22%22)

## Related publications

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

-   Publication
    
    ### [Statin dosing instructions, medication adherence, and low-density lipoprotein cholesterol: a cohort study of incident statin users.](https://www.sutterhealth.org/research/publications/cohort-study-of-incident-statin-users-1055312767)
    
    Marcum ZA, Huang HC, Romanelli RJ.
    
    J Gen Intern Med. doi: 10.1007/s11606-019-05180-7. \[Epub ahead of print\]
    
    2019 Jul 31
    
-   Publication
    
    ### [Nonrigid motion correction with 3D image-based navigators for coronary MR angiography.](https://www.sutterhealth.org/research/publications/motion-correction-3d-image-navig-ht-mra-1055312449)
    
    Luo J, Addy NO, Ingle RR, Baron CA, Cheng JY, Hu BS, Nishimura DG.
    
    Magn Reson Med. doi: 10.1002/mrm.26273. \[Epub ahead of print\]
    
    2016 May 13
    
-   Publication
    
    ### [Effect of financial incentives to physicians, patients, or both on lipid levels: a randomized clinical trial.](https://www.sutterhealth.org/research/publications/financial-md-and-pt-incentives-on-lipid-levels-1055312784)
    
    Asch DA, Troxel AB, Stewart WF, Sequist TD, Jones JB, Hirsch AG, Hoffer K, Zhu J, Wang W, Hodlofski A, Frasch AB, Weiner MG, Finnerty DD, Rosenthal MB, Gangemi K, Volpp KG.
    
    JAMA. 314(18):1926-35. doi: 10.1001/jama.2015.14850.
    
    2015 Nov 10
    
-   Publication
    
    ### [Non-contrast-enhanced peripheral angiography using a sliding interleaved cylinder acquisition.](https://www.sutterhealth.org/research/publications/noncontrast-enhance-periph-angiog-use-slincyl-1055312471)
    
    Kwon KT, Kerr AB, Wu HH, Hu BS, Brittain JH, Nishimura DG.
    
    Magn Reson Med. 74(3):727-38. doi: 10.1002/mrm.25452. Epub 2014 Sep 9.
    
    2015 Sep 01
    
-   Publication
    
    ### [Off-resonance-robust velocity-selective magnetization preparation for non-contrast-enhanced peripheral MR angiography.](https://www.sutterhealth.org/research/publications/off-reson-robust-veloc-select-magnetiz-prep-mra-1055312480)
    
    Shin T, Hu BS, Nishimura DG.
    
    Magn Reson Med. 70(5):1229-40. doi: 10.1002/mrm.24561. Epub 2012 Nov 28.
    
    2013 Nov 01
    

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research publications","item":"https://www.sutterhealth.org/research/publications"},{"@type":"ListItem","position":4,"name":"Clopidogrel pharmacogenomics: next steps."}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalScholarlyArticle","@id":"https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893#medicalscholarlyarticle","name":"Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.","headline":"Clopidogrel pharmacogenomics: next steps.","abstract":"Clopidogrel pharmacogenomics has received significant attention since a black box warning was announced by the Food and Drug Administration in March 2010. This has left clinicians in a difficult situation where many questions remain unanswered. In this brief viewpoint article, we ask some pointed questions of our own and outline the pathway that needs to be taken for clinical translation to occur.","description":"We outline the pathway for clopidogrel pharmacogenomics that needs to be taken for clinical translation to occur.","keywords":["Cardiovascular Diseases","Disease Management","Genetics","Health Policy","Pharmacoepidemiology"],"datePublished":"2010-10-01","url":"https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893","inLanguage":"en-US","identifier":[{"@type":"PropertyValue","propertyID":"PMID","value":"20965455"},{"@type":"PropertyValue","propertyID":"DOI","value":"10.1016/j.jcin.2010.08.012"}],"sameAs":["https://pubmed.ncbi.nlm.nih.gov/20965455/","https://doi.org/10.1016/j.jcin.2010.08.012"],"isPartOf":{"@type":"Periodical","name":"JACC Cardiovasc Interv"},"author":[{"@type":"Person","name":"Gladding P"},{"@type":"Person","name":"Panattoni L"},{"@type":"Person","name":"Webster M"},{"@type":"Person","name":"Cho L"},{"@type":"Person","name":"Ellis S"}],"sourceOrganization":{"@type":"MedicalOrganization","name":"Palo Alto Medical Foundation Research Institute"},"about":[{"@type":"DefinedTerm","name":"Cardiovascular Diseases","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Cardiovascular+Diseases%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Disease Management","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Disease+Management%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Genetics","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Genetics%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Health Policy","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Health+Policy%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Pharmacoepidemiology","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Pharmacoepidemiology%22%5D%7D%5D&verticalKey=research_publication"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893","breadcrumb":{"@id":"https://www.sutterhealth.org/research/publications/clopidogrel-pharmacogenomics-1055312893#breadcrumblist"}}}
```
